Potassium Citrate as a Preventive Treatment for Double-J Stent Encrustation: A Randomized Clinical Trial

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 181

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TUMS-4-1_006

تاریخ نمایه سازی: 1 تیر 1401

چکیده مقاله:

Introduction: This research was conducted to assess whether prophylactic citrate potassium can reduce double-J stent encrustation in patients with urolithiasis.Methods: In the present study, ۷۰ patients with urolithiasis were randomly assigned to two groups control [۲۲ men; mean age ۴۳ (۳۳-۵۵)] and intervention [۲۵ men; mean age, ۴۱ (۳۷-۵۶)] after meeting inclusion criteria. Potassium citrate (۱۰ mEq Alithoral tablet) was administered three times a day from double-J stent insertion until removal in the intervention group. For the control group, no treatment was given. It was examined after removing the stent, and laboratory tests were performed in encrustation. Moreover, blood and urine were collected for assessing creatinine, crystalluria, and pyuria. Information concerning the duration of double-J stent placement, the composition of urinary stone (calcium oxalate or other), number of attack episodes, type of double-J stent (one way or other), and smoking habit were collected.  Results: Three control group participants were excluded from the study due to missing follow-up. Patients of the two groups were matched for age, sex, duration of the double-J stent placement, and the number of attack episodes. There were significant differences in crystalluria and creatinine dosage between the two groups. Furthermore, double-J stent encrustation occurred in ۳ (۸.۸%) and ۱۱ (۳۴.۴%) patients of the intervention and control group, respectively, which showed a significant difference (P-value=۰.۰۱۲). Comparison between the intervention and control group revealed an odds ratio of ۱۸% (P-value=۰.۰۱۷) and ۱۵% (P-value=۰.۰۲۳) in the crude and adjusted model, respectively. Conclusion: Potassium citrate can significantly reduce double-J stent encrustation in patients with urolithiasis. Therefore, it is recommended that urologists consider citrate potassium as a preventive treatment for encrustation.

نویسندگان

Ali Tavoosian

Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Amirhossein Rahimnia

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Elham Tehranipour

Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Alireza Khajavi

Student Research Committee, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Saeed Tamehri Zadeh

Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Vahid Abedi Yarandi

Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Memon N, Talpur AA, Memon J. Indications and complications of ...
  • Lange D, Bidnur S, Hoag N, Chew BH. Ureteral stent-associated ...
  • Mirsadeghi SA, Tamehri Zadeh SS, Fakhr Yasseri A, Tabibi A, ...
  • Kawahara T, Ito H, Terao H, Yoshida M, Matsuzaki J. ...
  • Tomer N, Garden E, Small A, Palese M. Ureteral stent ...
  • Wang R, Neoh KG, Kang ET, Tambyah PA, Chiong E. ...
  • Kram W, Buchholz N, Hakenberg OW. Ureteral stent encrustation. Pathophysiology. ...
  • Aron M, Ansari MS, Singh I, Gautam G, Kolla SB, ...
  • Jafari Shahdani MR, Fattahi B, Mohseni MG, Aghamir SMK. Comparison ...
  • Zia H, Khatami F, Rahimi MR, Aghamir SMK. Combined Direct ...
  • Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, ...
  • Zerwekh JE, Odvina CV, Wuermser L-A, Pak CY. Reduction of ...
  • Aghamir SMK, Dadkhah Tehrani F, Khatami F, Zia H. Second-look ...
  • Caudarella R, Vescini F. Urinary citrate and renal stone disease: ...
  • Aghamir ZS, Shivarani S, Manafi Shabestari R. The Molecular Structure ...
  • Hamm LL, Hering-Smith KS. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinology and ...
  • Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali ...
  • Robinson MR, Leitao VA, Haleblian GE, Scales CD, Chandrashekar A, ...
  • Song Y, Hernandez N, Shoag J, Goldfarb DS, Eisner BH. ...
  • Grases F, Söhnel O, Costa-Bauza A, Ramis M, Wang Z. ...
  • Aghamir SMK, Khatami F, Zia H. Laparoscopic Injection of Methylene ...
  • Scarneciu I, Bratu OG, Cobelschi CP, Neculoiu CD, Scarneciu CC, ...
  • Singh I, Gupta N, Hemal A, Aron M, Seth A, ...
  • Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, ...
  • نمایش کامل مراجع